Huiqun Tian

Huiqun Tian


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2023 in Medicine
Verified
Journal Article
Open access
XHXiaoqing Mm Hao
Xiaoqing Mm Hao
XZXiaodi Mb Zhu
Xiaodi Mb Zhu
HTHuiqun Tian
Huiqun Tian
GLGuanxi Mb Lai
Guanxi Mb Lai
WZWei Zhang
Wei Zhang
SLSong Liu
Song Liu
Research has demonstrated that obesity is an important risk factor for cancer progression. Orlistat is a lipase inhibitor with promising therapeutic effects on obesity. In addition to being regarded as a slimming drug, a growing number of studies in recent years have suggested that orlistat has anti-tumor activities, while the underlying mechanism is still not well elucidated. This paper reviewed recent pharmacological effects and mechanisms of orlistat against tumors and found that orlistat can target cancer cells through activation or suppression of multiple signaling pathways. It can induce tumor cells apoptosis or death, interfere with tumor cells’ cycles controlling, suppress fatty acid synthase activity, increase ferroptosis, inhibit tumor angiogenesis, and improve tumor cells glycolytic. Thus, this review may shed new light on anti-tumor mechanism and drug repurposing of orlistat, and anti-tumor drug development.

1 December 2023 in Human Gene Therapy
Verified
Journal Article
Closed access
JLJiawen Li
Jiawen Li
CTChuxi Tang
Chuxi Tang
GLGuozheng Liang
Guozheng Liang
HTHuiqun Tian
Huiqun Tian
GLGuanxi Lai
Guanxi Lai
HSHongwei Shao
Hongwei Shao
The clustered regularly interspaced short palindromic repeat (CRISPR)- CRISPR-associated (Cas) system is a powerful genomic DNA editing tool. The increased applications of gene editing tools, including the CRISPR-Cas system, have contributed to recent advances in biological fields, such as genetic disease therapy, disease-associated gene screening and detection, and cancer therapy. However, the major limiting factor for the wide application of gene editing tools is gene editing efficiency. This review summarizes the recent advances in factors affecting the gene editing efficiency of the CRISPR-Cas9 system and the CRISPR-Cas9 system optimization strategies. The homology-directed repair efficiency-related signal pathways and the form and delivery method of the CRISPR-Cas9 system are the major factors that influence the repair efficiency of gene editing tools. Based on these influencing factors, several strategies have been developed to improve the repair efficiency of gene editing tools. This review provided novel insights for improving the repair efficiency of the CRISPR-Cas9 gene editing system, which may enable the development and improvement of gene editing tools.